As of May 30, 2026, Intellia Therapeutics's top three insider holders are Fred E Cohen (Director, 207.45K shares), Edward J Iii Dulac (Evp, Chief Financial Officer, 160.96K shares), James Basta (Evp, General Counsel, 156.79K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jean Francois Formela | - | 7,291 | 0 | 16 Jun, 2022 |
| Caroline Dorsa | - | 12,701 | 0 | 16 Jun, 2022 |
| Fred E Cohen | - | 207,453 | 0 | 07 Jan, 2026 |
| John F Crowley | - | 11,716 | 0 | 16 Jun, 2023 |
| Frank Verwiel | - | 25,948 | 0 | 13 Jun, 2025 |
| Brian Goff | - | 23,409 | 0 | 13 Jun, 2025 |
| William J Chase | - | 134,693 | 0 | 22 Aug, 2025 |
| Glenn Goddard | Evp, Chief Financial Officer | 69,213 | 0 | 05 Mar, 2024 |
| Jesse Goodman | - | 24,359 | 0 | 02 Jul, 2025 |
| James Basta | Evp, General Counsel | 156,794 | 0 | 03 Mar, 2026 |
| David Lebwohl | Evp, Chief Medical Officer | 131,192 | 0 | 03 Mar, 2026 |
| Edward J Iii Dulac | Evp, Chief Financial Officer | 160,963 | 0 | 03 Mar, 2026 |
| Muna Bhanji | - | 27,203 | 0 | 13 Jun, 2025 |
| Derek Hicks | Evp, Chief Business Officer | 59,878 | 0 | 07 Jan, 2025 |
| Eliana Clark | Evp, Chief Technical Officer | 93,864 | 0 | 03 Mar, 2026 |
| Michael P Dube | Vp, Chief Accounting Officer | 69,527 | 0 | 03 Mar, 2026 |
| Birgit C Schultes | Evp, Chief Scientific Officer | 137,733 | 0 | 03 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Mar, 2026 | James Basta | Common Stock | A | 46,080 | $0.00 | 158,005 | D | A |
| 01 Mar, 2026 | David Lebwohl | Common Stock | A | 9,943 | $0.00 | 131,192 | D | A |
| 01 Mar, 2026 | David Lebwohl | Common Stock | A | 9,943 | $0.00 | 131,192 | D | A |
| 01 Mar, 2026 | Birgit C Schultes | Common Stock | A | 39,200 | $0.00 | 137,733 | D | A |
| 01 Mar, 2026 | Birgit C Schultes | Common Stock | A | 39,200 | $0.00 | 137,733 | D | A |
| 01 Mar, 2026 | Michael P Dube | Common Stock | A | 17,250 | $0.00 | 69,527 | D | A |
| 01 Mar, 2026 | Edward J Iii Dulac | Common Stock | A | 61,280 | $0.00 | 160,963 | D | A |
| 01 Mar, 2026 | Eliana Clark | Common Stock | A | 7,353 | $0.00 | 94,471 | D | A |
| 02 Mar, 2026 | Eliana Clark | Common Stock | D | 607 | $13.78 | 93,864 | D | S |
| 02 Mar, 2026 | James Basta | Common Stock | D | 1,211 | $13.78 | 156,794 | D | S |
| 01 Mar, 2026 | Birgit C Schultes | Stock Option (right to buy) | A | 56,000 | $0.00 | 56,000 | D | A |
| 01 Mar, 2026 | David Lebwohl | Stock Option (right to buy) | A | 14,204 | $0.00 | 14,204 | D | A |
| 01 Mar, 2026 | Edward J Iii Dulac | Stock Option (right to buy) | A | 87,543 | $0.00 | 87,543 | D | A |
| 01 Mar, 2026 | David Lebwohl | Stock Option (right to buy) | A | 14,204 | $0.00 | 14,204 | D | A |
| 01 Mar, 2026 | Birgit C Schultes | Stock Option (right to buy) | A | 56,000 | $0.00 | 56,000 | D | A |
| 01 Mar, 2026 | James Basta | Stock Option (right to buy) | A | 65,829 | $0.00 | 65,829 | D | A |
| 01 Mar, 2026 | Eliana Clark | Stock Option (right to buy) | A | 10,505 | $0.00 | 10,505 | D | A |
| 05 Jan, 2026 | Birgit C Schultes | Common Stock | D | 8,508 | $9.21 | 98,533 | D | S |
| 05 Jan, 2026 | David Lebwohl | Common Stock | D | 11,903 | $9.21 | 121,249 | D | S |
| 05 Jan, 2026 | Fred E Cohen | Common Stock | A | 150,000 | $9.35 | 207,453 | D | P |